article_analysis.json

{
	"name": "toi",
	"type": "news_intel",
	"guid": "de74a25f-e1a6-40da-ad4c-9a67af6414fc",
	"title": "Cheer for India: Novavax Jab\nShows 90% Efficacy, J&J 66%\n\f",
	"content": "Big boost to inoculation\ndrive as Novavax has\ntieup with Serum,\n\nJ&J with Biological E\n\nOur Bureau\n\nMumbai: US drug makers Nova-\nvax and Johnson & Johnson said\ntheir Covid vaccine candidates\nshowed encouraging phase 8 trial\nresults, which should boost Indi-\na\u2019s inoculation programme. Both\nnave tied up with local partners\u2014\nNovavax with Serum Institute of\nIndia (SII) and J&J with Hydera-\noad-based Biological E.\n\nNovavax said its NVX-CoV2373\nJemonstrated a 90% efficacy in\n\nphase 3 trials in the UK, taking it\ncloser to approval by the UK he-\nalth authorities. J&J\u2019s single-do-\nse Covid vaccine demonstrated\nan overall efficacy of 66%, while\nit showed 85 % efficacy in preven-\nting death (severe disease)\nacross allage and ethnic groups.\n\n\u201cThe potential to significantly\nreduce the burden of severe dise-\nase, by providing an effectiveand\nwell-tolerated vaccine with just\none immunisation, is a critical\ncomponent of the global public\nhealth response,\u201d said Paul Stof-\nfels, vice chairman of the execu-\ntive committee and chief scienti-\nfic officer at J&J.\n\nNovavax enrolled more than\n\n3,308,734 | 440,681\n\nTOTAL ON JAN 29\nVACCINATIONS *TILL 7 PM\n\n15,000 participants aged 18-84 ye-\nars, of whom 27% were over 65.\nThe vaccine was shown to work\nagainst the more infectious UK\nstrain. However, its efficacy aga-\ninst the group detected with the\nSouth Africa strain was 60%. No-\nvavax is running a separate trial\nin the US, where it has recruited\n16,000 participants and is expec-\nted to enrol another 14,000 by Fe-\nbruary. The company has alrea-\ndy submitted data for approval to\nthe UK authorities.\n\n\u201cThe efficacy shown against\nthe emerging variants is also ex-\ntremely encouraging,\u201d said Clive\nDix, chair of the UK Vaccine\nTaskforce, in a statement about\nthe Novavax candidate. \u201cThis is\nan incredible achievement that\nwillensure we can protect indivi-\nduals in the UK and the rest of\nthe world from this virus.\u201d\n\f",
	"author": null,
	"source": null,
	"date_pub": null,
	"date_added": "2021-07-03T07:21:26.867921",
	"summary": "Novavax said its NVX-CoV2373 Jemonstrated a 90 efficacy in phase 3 trials in the UK taking it closer to approval by the UK he- alth authorities J&J\u2019s single-do- se Covid vaccine demonstrated an overall efficacy of 66% while it showed 85 efficacy in preven- ting death (severe disease) across allage and ethnic groupsBig boost to inoculation drive as Novavax has tieup with Serum, J&J with Biological E Our Bureau Mumbai US drug makers Nova- vax and Johnson Johnson said their Covid vaccine candidates showed encouraging phase 8 trial results which should boost Indi- a\u2019s inoculation programme Both nave tied up with local partners\u2014 Novavax with Serum Institute of India (SII and J&J with Hydera- oad-based Biological E",
	"image": "/platform/deepsight/newspaper/newspaper/test_data/article.jpg",
	"video": null,
	"sentiment": "positive",
	"sentiment_score": null,
	"timestamp": null,
	"attributes": null,
	"relations": null,
	"profiles": [{
		"name": "Novavax",
		"type": "Organization",
		"guid": "Q17072200",
		"detail": "company in Gaithersburg, Maryland",
		"image": "https://upload.wikimedia.org/wikipedia/commons/4/47/Novavax_research_and_development.jpg",
		"video": null,
		"date_pub": "2020-08-03T10:30:00",
		"date_updated": null,
		"summary": null,
		"timestamp": null,
		"attributes": [],
		"relations": []
	}, {
		"name": "Mumbai",
		"type": "Organization",
		"guid": "Q1156",
		"detail": "capital city and district in Maharashtra, India",
		"image": "https://upload.wikimedia.org/wikipedia/commons/3/3a/Mumbai_03-2016_10_skyline_of_Lotus_Colony.jpg",
		"video": null,
		"date_pub": "2020-08-03T10:30:00",
		"date_updated": null,
		"summary": null,
		"timestamp": null,
		"attributes": [],
		"relations": []
	}, {
		"name": "Division of Indi",
		"type": "Location",
		"guid": "Q2973417",
		"detail": "Australian federal electoral division",
		"image": "na",
		"video": null,
		"date_pub": "2020-08-03T10:30:00",
		"date_updated": null,
		"summary": null,
		"timestamp": null,
		"attributes": [],
		"relations": []
	}, {
		"name": "Serum Institute of India",
		"type": "Organization",
		"guid": "Q3480001",
		"detail": "Indian biotechnological company, vaccine manufacturer",
		"image": "na",
		"video": null,
		"date_pub": "2020-08-03T10:30:00",
		"date_updated": null,
		"summary": null,
		"timestamp": null,
		"attributes": [],
		"relations": []
	}, {
		"name": "India",
		"type": "Organization",
		"guid": "Q668",
		"detail": "sovereign state in South Asia",
		"image": "na",
		"video": null,
		"date_pub": "2020-08-03T10:30:00",
		"date_updated": null,
		"summary": null,
		"timestamp": null,
		"attributes": [],
		"relations": []
	}, {
		"name": "United Kingdom",
		"type": "Organization",
		"guid": "Q145",
		"detail": "country in Western Europe",
		"image": "na",
		"video": null,
		"date_pub": "2020-08-03T10:30:00",
		"date_updated": null,
		"summary": null,
		"timestamp": null,
		"attributes": [],
		"relations": []
	}, {
		"name": "South Africa",
		"type": "Organization",
		"guid": "Q258",
		"detail": "sovereign state in Southern Africa",
		"image": "https://upload.wikimedia.org/wikipedia/commons/f/f9/Ciudad_del_Cabo_desde_Cabeza_de_Le%C3%B3n%2C_Sud%C3%A1frica%2C_2018-07-22%2C_DD_34.jpg",
		"video": null,
		"date_pub": "2020-08-03T10:30:00",
		"date_updated": null,
		"summary": null,
		"timestamp": null,
		"attributes": [],
		"relations": []
	}]
}